Radiotherapy Planning, Computer-AssistedProton TherapyPhysical Therapy ModalitiesRadiotherapy DosageRadiometryFilm DosimetryRadiation InjuriesRadiation DosageRadiotherapy, Intensity-ModulatedAntineoplastic AgentsRadiotherapy, ConformalRadiation, IonizingDose-Response Relationship, RadiationTreatment OutcomeRadiation ToleranceRadiotherapyRadiationCombined Modality TherapyNeoplasmsCell Line, TumorRadiation ProtectionRadiation OncologyDrug Screening Assays, AntitumorRadiation MonitoringTime FactorsPhantoms, ImagingDoxorubicinDose FractionationRadiotherapy, AdjuvantGenetic TherapyRadiation PneumonitisCisplatinApoptosisBrachytherapyRadiation-Sensitizing AgentsDrug Resistance, NeoplasmCell SurvivalAntineoplastic Agents, PhytogenicNeoplasms, Radiation-InducedGamma RaysRadiation Injuries, ExperimentalRadiosurgeryAntibiotics, AntineoplasticBrain NeoplasmsBreast NeoplasmsDrug Delivery SystemsCosmic RadiationTumor Cells, CulturedXenograft Model Antitumor AssaysMice, NudeDNA DamageNeoplasm Recurrence, LocalRetrospective StudiesRadiotherapy, Computer-AssistedAntineoplastic Combined Chemotherapy ProtocolsDrug CarriersCranial IrradiationHead and Neck NeoplasmsEtoposideParticle AcceleratorsPaclitaxelRadiotherapy, Image-GuidedCell ProliferationFluorouracilRadiation-Protective AgentsBackground RadiationNeoplasm StagingEllipticinesRadiodermatitisProstatic NeoplasmsFollow-Up StudiesAdenocarcinomaLung NeoplasmsCarcinoma, Squamous CellCamptothecinRadiotherapy, High-EnergyUltraviolet RaysDose-Response Relationship, DrugSurvival AnalysisTomography, X-Ray ComputedTumor BurdenOrgans at RiskDrug Resistance, MultipleInhibitory Concentration 50P-GlycoproteinSurvival RateCobalt RadioisotopesCell CycleRadiation EffectsMolecular StructureDisease-Free SurvivalChemoradiotherapyPrognosisDrug DesignMastectomy, SegmentalDrug Synergism